Wellington Management Group LLP Sells 505,290 Shares of ICU Medical, Inc. (NASDAQ:ICUI)

Wellington Management Group LLP lessened its holdings in ICU Medical, Inc. (NASDAQ:ICUI - Free Report) by 35.0% during the third quarter, according to the company in its most recent disclosure with the SEC. The firm owned 937,496 shares of the medical instruments supplier's stock after selling 505,290 shares during the quarter. Wellington Management Group LLP owned about 3.83% of ICU Medical worth $170,831,000 at the end of the most recent quarter.

Other hedge funds and other institutional investors have also bought and sold shares of the company. Hexagon Capital Partners LLC grew its holdings in ICU Medical by 162.7% in the third quarter. Hexagon Capital Partners LLC now owns 197 shares of the medical instruments supplier's stock worth $36,000 after purchasing an additional 122 shares during the period. Allworth Financial LP grew its holdings in ICU Medical by 100.0% in the third quarter. Allworth Financial LP now owns 200 shares of the medical instruments supplier's stock worth $36,000 after purchasing an additional 100 shares during the period. Innealta Capital LLC purchased a new stake in ICU Medical in the second quarter worth about $32,000. Venturi Wealth Management LLC grew its holdings in shares of ICU Medical by 1,510.0% during the third quarter. Venturi Wealth Management LLC now owns 322 shares of the medical instruments supplier's stock valued at $59,000 after buying an additional 302 shares during the last quarter. Finally, Point72 Hong Kong Ltd purchased a new stake in shares of ICU Medical during the third quarter valued at approximately $72,000. Hedge funds and other institutional investors own 96.10% of the company's stock.

Insiders Place Their Bets

In related news, COO Christian B. Voigtlander sold 1,430 shares of ICU Medical stock in a transaction dated Wednesday, November 27th. The shares were sold at an average price of $158.00, for a total transaction of $225,940.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Also, CEO Vivek Jain sold 12,000 shares of ICU Medical stock in a transaction dated Friday, November 1st. The stock was sold at an average price of $171.84, for a total transaction of $2,062,080.00. Following the transaction, the chief executive officer now directly owns 104,593 shares of the company's stock, valued at approximately $17,973,261.12. This represents a 10.29 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold 40,364 shares of company stock valued at $6,869,878 in the last three months. Corporate insiders own 6.70% of the company's stock.

Analyst Upgrades and Downgrades

A number of research analysts recently weighed in on ICUI shares. Jefferies Financial Group started coverage on shares of ICU Medical in a research report on Monday, October 14th. They set a "hold" rating and a $183.00 price objective on the stock. Needham & Company LLC restated a "hold" rating on shares of ICU Medical in a research report on Wednesday, November 13th. Raymond James raised their price objective on shares of ICU Medical from $158.00 to $190.00 and gave the company an "outperform" rating in a research report on Thursday, September 12th. KeyCorp raised their price objective on shares of ICU Medical from $198.00 to $209.00 and gave the company an "overweight" rating in a research report on Wednesday, November 13th. Finally, StockNews.com upgraded shares of ICU Medical from a "hold" rating to a "buy" rating in a research report on Wednesday, November 20th. Two equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the company's stock. According to MarketBeat.com, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $173.00.

ICU Medical Price Performance

ICUI traded up $5.57 during trading on Monday, hitting $161.31. 221,036 shares of the company traded hands, compared to its average volume of 272,122. ICU Medical, Inc. has a 1 year low of $83.26 and a 1 year high of $196.26. The stock's 50-day simple moving average is $172.78 and its two-hundred day simple moving average is $149.53. The company has a debt-to-equity ratio of 0.75, a quick ratio of 1.03 and a current ratio of 2.29.

About ICU Medical

ICU Medical, Inc, together with its subsidiaries, develops, manufactures, and sells medical devices used in infusion therapy, vascular access, and vital care applications worldwide. Its infusion therapy products include needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoClave and ChemoLock closed system transfer devices, which are used to limit the escape of hazardous drugs or vapor concentrations, block the transfer of environmental contaminants into the system, and eliminates the risk of needlestick injury; Tego needle free connectors; Deltec GRIPPER non-coring needles for portal access; and ClearGuard, SwabCap, and SwabTip disinfection caps.